Malaria remains the major source of health malaise in Sub-Saharan
Africa. It is responsible for recurrent febrile illnesses that are a
major source of worry for all ages, especially for mothers of children
under five years of age. It solicits a monthly allocation of household
budget to either treatment or prophylaxis thereby stealing from a much
needed, and already very limited resources. Furthermore, over diagnosis
of malaria resulting from poor clinical practice or laboratory practice
increases pressure on outpatients for anti-malarial drugs which in turn
tends to exacerbate poverty. Can antigen capture assays without pan
malarial monoclonal antibodies be trusted in diagnosing malaria in
endemic and remote areas? Are dipsticks other than HRP-2 dipsticks
available in remote settings in West Africa?